{"pmid":32156332,"title":"Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020.","text":["Potential scenarios for the progression of a COVID-19 epidemic in the European Union and the European Economic Area, March 2020.","Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens.","Euro Surveill","Johnson, Helen C","Gossner, Celine M","Colzani, Edoardo","Kinsman, John","Alexakis, Leonidas","Beaute, Julien","Wurz, Andrea","Tsolova, Svetla","Bundle, Nick","Ekdahl, Karl","32156332"],"abstract":["Two months after the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the possibility of established and widespread community transmission in the European Union and European Economic Area (EU/EEA) is becoming more likely. We provide scenarios for use in preparedness for a possible widespread epidemic. The EU/EEA is moving towards the 'limited sustained transmission' phase. We propose actions to prepare for potential mitigation phases and coordinate efforts to protect the health of citizens."],"journal":"Euro Surveill","authors":["Johnson, Helen C","Gossner, Celine M","Colzani, Edoardo","Kinsman, John","Alexakis, Leonidas","Beaute, Julien","Wurz, Andrea","Tsolova, Svetla","Bundle, Nick","Ekdahl, Karl"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32156332","week":"202011|Mar 09 - Mar 15","doi":"10.2807/1560-7917.ES.2020.25.9.2000202","keywords":["COVID-19","Europe","SARS-CoV-2","coronavirus","pandemic","preparedness"],"source":"PubMed","locations":["European"],"weight":0,"_version_":1661359647857049600,"score":6.7365713,"similar":[{"pmid":32046815,"pmcid":"PMC7029448","title":"Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.","text":["Laboratory readiness and response for novel coronavirus (2019-nCoV) in expert laboratories in 30 EU/EEA countries, January 2020.","Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.","Euro Surveill","Reusken, Chantal B E M","Broberg, Eeva K","Haagmans, Bart","Meijer, Adam","Corman, Victor M","Papa, Anna","Charrel, Remi","Drosten, Christian","Koopmans, Marion","Leitmeyer, Katrin","On Behalf Of Evd-LabNet And Erli-Net","32046815"],"abstract":["Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers."],"journal":"Euro Surveill","authors":["Reusken, Chantal B E M","Broberg, Eeva K","Haagmans, Bart","Meijer, Adam","Corman, Victor M","Papa, Anna","Charrel, Remi","Drosten, Christian","Koopmans, Marion","Leitmeyer, Katrin","On Behalf Of Evd-LabNet And Erli-Net"],"date":"2020-02-13T11:00:00Z","year":2020,"_id":"32046815","week":"20207|Feb 10 - Feb 16","doi":"10.2807/1560-7917.ES.2020.25.6.2000082","keywords":["2019-nCoV","coronavirus","emerging infections","laboratory","response","zoonoses"],"source":"PubMed","topics":["Treatment"],"weight":1,"_version_":1661359647233146880,"score":279.10852},{"pmid":31992387,"pmcid":"PMC6988269","title":"Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","text":["Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.","BACKGROUND: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. AIM: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. METHODS: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. RESULTS: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project. CONCLUSION: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks.","Euro Surveill","Corman, Victor M","Landt, Olfert","Kaiser, Marco","Molenkamp, Richard","Meijer, Adam","Chu, Daniel K W","Bleicker, Tobias","Brunink, Sebastian","Schneider, Julia","Schmidt, Marie Luisa","Mulders, Daphne G J C","Haagmans, Bart L","van der Veer, Bas","van den Brink, Sharon","Wijsman, Lisa","Goderski, Gabriel","Romette, Jean-Louis","Ellis, Joanna","Zambon, Maria","Peiris, Malik","Goossens, Herman","Reusken, Chantal","Koopmans, Marion P G","Drosten, Christian","31992387"],"abstract":["BACKGROUND: The ongoing outbreak of the recently emerged novel coronavirus (2019-nCoV) poses a challenge for public health laboratories as virus isolates are unavailable while there is growing evidence that the outbreak is more widespread than initially thought, and international spread through travellers does already occur. AIM: We aimed to develop and deploy robust diagnostic methodology for use in public health laboratory settings without having virus material available. METHODS: Here we present a validated diagnostic workflow for 2019-nCoV, its design relying on close genetic relatedness of 2019-nCoV with SARS coronavirus, making use of synthetic nucleic acid technology. RESULTS: The workflow reliably detects 2019-nCoV, and further discriminates 2019-nCoV from SARS-CoV. Through coordination between academic and public laboratories, we confirmed assay exclusivity based on 297 original clinical specimens containing a full spectrum of human respiratory viruses. Control material is made available through European Virus Archive - Global (EVAg), a European Union infrastructure project. CONCLUSION: The present study demonstrates the enormous response capacity achieved through coordination of academic and public laboratories in national and European research networks."],"journal":"Euro Surveill","authors":["Corman, Victor M","Landt, Olfert","Kaiser, Marco","Molenkamp, Richard","Meijer, Adam","Chu, Daniel K W","Bleicker, Tobias","Brunink, Sebastian","Schneider, Julia","Schmidt, Marie Luisa","Mulders, Daphne G J C","Haagmans, Bart L","van der Veer, Bas","van den Brink, Sharon","Wijsman, Lisa","Goderski, Gabriel","Romette, Jean-Louis","Ellis, Joanna","Zambon, Maria","Peiris, Malik","Goossens, Herman","Reusken, Chantal","Koopmans, Marion P G","Drosten, Christian"],"date":"2020-01-30T11:00:00Z","year":2020,"_id":"31992387","week":"20205|Jan 27 - Feb 02","doi":"10.2807/1560-7917.ES.2020.25.3.2000045","keywords":["*2019-nCoV","*RT-PCR","*Wuhan","*diagnostics","*laboratory","*novel coronavirus","*outbreak","*testing"],"source":"PubMed","locations":["European"],"topics":["Treatment"],"weight":1,"_version_":1661359647044403200,"score":140.80365},{"pmid":32156327,"title":"First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.","text":["First cases of coronavirus disease 2019 (COVID-19) in the WHO European Region, 24 January to 21 February 2020.","In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases.","Euro Surveill","Spiteri, Gianfranco","Fielding, James","Diercke, Michaela","Campese, Christine","Enouf, Vincent","Gaymard, Alexandre","Bella, Antonino","Sognamiglio, Paola","Sierra Moros, Maria Jose","Riutort, Antonio Nicolau","Demina, Yulia V","Mahieu, Romain","Broas, Markku","Bengner, Malin","Buda, Silke","Schilling, Julia","Filleul, Laurent","Lepoutre, Agnes","Saura, Christine","Mailles, Alexandra","Levy-Bruhl, Daniel","Coignard, Bruno","Bernard-Stoecklin, Sibylle","Behillil, Sylvie","van der Werf, Sylvie","Valette, Martine","Lina, Bruno","Riccardo, Flavia","Nicastri, Emanuele","Casas, Inmaculada","Larrauri, Amparo","Salom Castell, Magdalena","Pozo, Francisco","Maksyutov, Rinat A","Martin, Charlotte","Van Ranst, Marc","Bossuyt, Nathalie","Siira, Lotta","Sane, Jussi","Tegmark-Wisell, Karin","Palmerus, Maria","Broberg, Eeva K","Beaute, Julien","Jorgensen, Pernille","Bundle, Nick","Pereyaslov, Dmitriy","Adlhoch, Cornelia","Pukkila, Jukka","Pebody, Richard","Olsen, Sonja","Ciancio, Bruno Christian","32156327"],"abstract":["In the WHO European Region, COVID-19 surveillance was implemented 27 January 2020. We detail the first European cases. As at 21 February, nine European countries reported 47 cases. Among 38 cases studied, 21 were linked to two clusters in Germany and France, 14 were infected in China. Median case age was 42 years; 25 were male. Late detection of the clusters' index cases delayed isolation of further local cases. As at 5 March, there were 4,250 cases."],"journal":"Euro Surveill","authors":["Spiteri, Gianfranco","Fielding, James","Diercke, Michaela","Campese, Christine","Enouf, Vincent","Gaymard, Alexandre","Bella, Antonino","Sognamiglio, Paola","Sierra Moros, Maria Jose","Riutort, Antonio Nicolau","Demina, Yulia V","Mahieu, Romain","Broas, Markku","Bengner, Malin","Buda, Silke","Schilling, Julia","Filleul, Laurent","Lepoutre, Agnes","Saura, Christine","Mailles, Alexandra","Levy-Bruhl, Daniel","Coignard, Bruno","Bernard-Stoecklin, Sibylle","Behillil, Sylvie","van der Werf, Sylvie","Valette, Martine","Lina, Bruno","Riccardo, Flavia","Nicastri, Emanuele","Casas, Inmaculada","Larrauri, Amparo","Salom Castell, Magdalena","Pozo, Francisco","Maksyutov, Rinat A","Martin, Charlotte","Van Ranst, Marc","Bossuyt, Nathalie","Siira, Lotta","Sane, Jussi","Tegmark-Wisell, Karin","Palmerus, Maria","Broberg, Eeva K","Beaute, Julien","Jorgensen, Pernille","Bundle, Nick","Pereyaslov, Dmitriy","Adlhoch, Cornelia","Pukkila, Jukka","Pebody, Richard","Olsen, Sonja","Ciancio, Bruno Christian"],"date":"2020-03-12T11:00:00Z","year":2020,"_id":"32156327","week":"202011|Mar 09 - Mar 15","doi":"10.2807/1560-7917.ES.2020.25.9.2000178","keywords":["COVID-19","Novel coronavirus","SARS","SARS-COV-2","coronavirus disease 2019"],"source":"PubMed","locations":["France","Germany","European","China"],"countries":["France","China","Germany"],"countries_codes":["FRA|France","CHN|China","DEU|Germany"],"topics":["Case Report"],"weight":1,"_version_":1661359647853903875,"score":115.08313},{"pmid":32106216,"title":"Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.","text":["Update: Public Health Response to the Coronavirus Disease 2019 Outbreak - United States, February 24, 2020.","An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities.","MMWR Morb Mortal Wkly Rep","Jernigan, Daniel B","32106216"],"abstract":["An outbreak of coronavirus disease 2019 (COVID-19) caused by the 2019 novel coronavirus (SARS-CoV-2) began in Wuhan, Hubei Province, China in December 2019, and has spread throughout China and to 31 other countries and territories, including the United States (1). As of February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases in locations outside mainland China (1). There have been 2,462 associated deaths worldwide; no deaths have been reported in the United States. Fourteen cases have been diagnosed in the United States, and an additional 39 cases have occurred among repatriated persons from high-risk settings, for a current total of 53 cases within the United States. This report summarizes the aggressive measures (2,3) that CDC, state and local health departments, multiple other federal agencies, and other partners are implementing to slow and try to contain transmission of COVID-19 in the United States. These measures require the identification of cases and contacts of persons with COVID-19 in the United States and the recommended assessment, monitoring, and care of travelers arriving from areas with substantial COVID-19 transmission. Although these measures might not prevent widespread transmission of the virus in the United States, they are being implemented to 1) slow the spread of illness; 2) provide time to better prepare state and local health departments, health care systems, businesses, educational organizations, and the general public in the event that widespread transmission occurs; and 3) better characterize COVID-19 to guide public health recommendations and the development and deployment of medical countermeasures, including diagnostics, therapeutics, and vaccines. U.S. public health authorities are monitoring the situation closely, and CDC is coordinating efforts with the World Health Organization (WHO) and other global partners. Interim guidance is available at https://www.cdc.gov/coronavirus/index.html. As more is learned about this novel virus and this outbreak, CDC will rapidly incorporate new knowledge into guidance for action by CDC, state and local health departments, health care providers, and communities."],"journal":"MMWR Morb Mortal Wkly Rep","authors":["Jernigan, Daniel B"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32106216","week":"20209|Feb 24 - Mar 01","doi":"10.15585/mmwr.mm6908e1","source":"PubMed","locations":["United States","Hubei","USA","Wuhan","China"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["General Info"],"weight":1,"_version_":1661359647525699584,"score":111.25458},{"pmid":32181873,"title":"Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19.","text":["Tabletop exercise to prepare institutions of higher education for an outbreak of COVID-19.","Preparing for public health emergencies is an ongoing process and involves a variety of approaches and tools. Tabletop exercises are one of the tools designed to simulate the emergence of a public health emergency and address some or all of the phases of emergency management: mitigation, preparedness, response, and recovery.1 They typically are designed to include participation of stakeholders from diverse and complementary backgrounds, including command, operations, logistics, planning, and finance.2 Effective tabletop exercises provide a plausible scenario that require cooperation and communication from these functional areas. Tabletops also require forward thinking and planning in a variety of scenarios. When a public health emergency occurs, decision makers may be overwhelmed with decisions that need their immediate attention. Tabletop exercises can provide a framework to help decision makers anticipate future challenges, which may provide the mental model encompassing knowledge and insights that inform both current and future decisions.","J Emerg Manag","Wendelboe, Aaron M","Miller, Amanda","Drevets, Douglas","Salinas, Linda","Miller, E J","Jackson, Dalton","Chou, Ann","Raines, Jill","32181873"],"abstract":["Preparing for public health emergencies is an ongoing process and involves a variety of approaches and tools. Tabletop exercises are one of the tools designed to simulate the emergence of a public health emergency and address some or all of the phases of emergency management: mitigation, preparedness, response, and recovery.1 They typically are designed to include participation of stakeholders from diverse and complementary backgrounds, including command, operations, logistics, planning, and finance.2 Effective tabletop exercises provide a plausible scenario that require cooperation and communication from these functional areas. Tabletops also require forward thinking and planning in a variety of scenarios. When a public health emergency occurs, decision makers may be overwhelmed with decisions that need their immediate attention. Tabletop exercises can provide a framework to help decision makers anticipate future challenges, which may provide the mental model encompassing knowledge and insights that inform both current and future decisions."],"journal":"J Emerg Manag","authors":["Wendelboe, Aaron M","Miller, Amanda","Drevets, Douglas","Salinas, Linda","Miller, E J","Jackson, Dalton","Chou, Ann","Raines, Jill"],"date":"2020-03-18T11:00:00Z","year":2020,"_id":"32181873","week":"202012|Mar 16 - Mar 22","doi":"10.5055/jem.2020.0463","source":"PubMed","weight":0,"_version_":1661542092027985920,"score":104.249405}]}